Latest AI and machine learning research in oncology/hematology for healthcare professionals.
OBJECTIVES: This study investigated serum pentosidine levels as an advanced glycation end product (AGE)-related marker of bone matrix deterioration and examined the association between b/tsDMARD use and prevalent vertebral fractures in patients with RA in clinical remission. METHODS: Seventy-six patients with RA in clinical remission (DAS28-CRP < 2.3) were included. Serum pentosidine, bone turnove...
BACKGROUND: The rising incidence of cancer, increasing life expectancy and complex personalized treatment concepts pose considerable challenges for the healthcare system. Artificial intelligence (AI)-in particular machine learning (ML), deep learning (DL), and large language models (LLMs)-offers promising potential for supporting therapeutic decisions in urological oncology. OBJECTIVE: The aim of ...
In the rapidly developing world, artificial intelligence (AI) is one of the emerging applications in the medical domain. Early detection of cancer is ...
OBJECTIVE: To assess the diagnostic performance of semen RNA-based biomarkers for detecting prostate cancer and differentiating cancer grade groups. M...
BACKGROUND: Artificial intelligence (AI) is considered to be a leading technology in radiation medical physics, which has the potential for improving ...
Glioblastoma is a highly aggressive primary brain tumor with near-universal recurrence despite maximal safe resection followed by standard chemoradiat...
Brain tumors exhibit high heterogeneity in morphology, texture, and location, making accurate recognition and segmentation critical for clinical diagn...
Precision oncology faces critical challenges in interpreting complex cellular signals and predicting drug responses across heterogeneous cancer enviro...
Emerging evidence highlights hypoxia-responsive long non-coding RNAs (lncRNAs) as potential modulators in tumor biology. In this study, we explored th...
Generative adversarial networks (GANs) offer potential in cross-modality image translation, but their application in pituitary adenomas remains uncert...
Computational Pathology is a novel discipline at the intersection of pathology and computer science, driven by the recent advances in machine learning...
Triple-negative breast cancer (TNBC) is an aggressive subtype lacking effective targeted therapies. Although immune checkpoint inhibitors such as pemb...
OBJECTIVES: This study aims to develop and evaluate a trustworthy and ethical-by-design machine learning (ML) framework for predicting 5-year cancer s...
BACKGROUND: Missing data is a challenge in clinical research, especially in real-world data (RWD), where complete case analysis can bias results and r...
BACKGROUND: Lung adenocarcinoma presenting as ground-glass nodules (GGNs) comprises three invasive subtypes (adenocarcinoma in situ [AIS], minimally i...
BACKGROUND: Accurate grading and prognostic assessment of glioma requires integrating key molecular biomarkers, including IDH mutation status and the ...
BACKGROUND: Traditional auscultation, heavily dependent on the subjective judgment of physicians, can lead to variability in diagnoses. This study aim...
BACKGROUND: Multidisciplinary tumor boards (MDTBs) play a central role in breast cancer management by integrating imaging findings with clinical and p...
BACKGROUND: The prognosis for patients with glioblastoma (GBM) remains extremely poor, a challenge largely attributable to the complex nature of its m...
Metastatic lymph nodes (LNs) represent a major barrier to effective drug delivery in cancer therapy. To address this challenge, a lymphatic drug deliv...